FDA Approved: TAVABOROLE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved Tavaborole as a generic product under ANDA212294 from Zydus Lifesciences Limited for the treatment of onychomycosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis

Drugs mentioned

• Tavaborole (Tavaborole)

Snippet

ORIG AP for TAVABOROLE (TAVABOROLE)